<DOC>
	<DOC>NCT02615626</DOC>
	<brief_summary>The purpose of this study was to evaluate visfatin levels in different stages of periodontal diseases and health, moreover the effect of non-surgical periodontal therapy on visfatin levels in Gingival Crevicular Fluid (GCF) and Serum.</brief_summary>
	<brief_title>Visfatin Levels Before and After Periodontal Treatment</brief_title>
	<detailed_description>Total of 45 patients were divided into three groups based on their clinical and radiographical examination. Group 1 chronic periodontitis (n: 15), group 2 plaque induced gingivitis (n: 15) and group 3 Periodontal health (n: 15). GCF and serum samples were collected before treatment and 1, 3, 6 months after treatment and were assayed using enzyme linked immunosorbent assay kit.</detailed_description>
	<mesh_term>Periodontal Diseases</mesh_term>
	<mesh_term>Gingival Diseases</mesh_term>
	<criteria>Group 1 GI&gt;1, PPD≥5mm, CAL≥5mm with alveolar bone loss radiographically. Systematically healthy patients Group 2 No alveolar bone and attachment loss Inflammation signs such as redness, edema and increased BOP levels, GI≥2, PPD≤3mm, CAL≤3mm. Systematically healthy patients Group 3 No bone and attachment loss, GI=0, PPD≤3mm, CAL≤3mm Systematically healthy patients Exclusion Criteria for all groups: Aggressive Periodontitis, Oral pathologies, Patients with any other systemic diseases, Pregnant women and those in the lactation period, Patients with smoking habit and taking medication Patients received periodontal therapy in last 6 months</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Visfatin</keyword>
	<keyword>GCF</keyword>
	<keyword>serum</keyword>
	<keyword>Non-surgical Periodontal Treatment.</keyword>
</DOC>